CCCC - C4 Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CCCC is currently covered by 9 analysts with an average price target of $14.29. This is a potential upside of $12.75 (827.92%) from yesterday's end of day stock price of $1.54.

C4 Therapeutics 's activity chart (see below) currently has 33 price targets and 44 ratings on display. The stock rating distribution of CCCC is 35% HOLD, 60% BUY and 5% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34.09% with an average time for these price targets to be met of 42.73 days.

Highest price target for CCCC is $20, Lowest price target is $12, average price target is $11.57.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 19-Dec-2024. First documented stock forecast 27-Oct-2020.

Currently out of the existing stock ratings of CCCC, 7 are a HOLD (35%), 12 are a BUY (60%), 1 are a SELL (5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$10.26 (589.66%)

$8

4 months 20 days ago
(19-Dec-2024)

4/6 (66.67%)

$8.15 (211.69%)

147

Buy

$20

$18.26 (1049.43%)

9 months 3 days ago
(06-Aug-2024)

0/2 (0%)

$14 (233.33%)

Buy

$14

$12.26 (704.60%)

$13

1 years ago
(09-May-2024)

4/8 (50%)

$7.2 (105.88%)

102

Buy

$14

$12.26 (704.60%)

$15

1 years 2 months 5 days ago
(04-Mar-2024)

1/3 (33.33%)

$3.32 (31.09%)

29

$8

$6.26 (359.77%)

$3

1 years 2 months 13 days ago
(26-Feb-2024)

4/4 (100%)

$-1.51 (-15.88%)

39

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CCCC (C4 Therapeutics ) average time for price targets to be met?

On average it took 42.73 days on average for the stock forecasts to be realized with a an average price target met ratio 34.09

Which analyst has the current highest performing score on CCCC (C4 Therapeutics ) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on CCCC (C4 Therapeutics )?

Derek Archila works at WELLS FARGO and has 8 price targets and 6 ratings on CCCC

Which analyst is the currently most bullish on CCCC (C4 Therapeutics )?

Matthew Luchini with highest potential upside - $112.14

Which analyst is the currently most reserved on CCCC (C4 Therapeutics )?

Colin Bristow with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?